http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008189638-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2617a062e32c692ade5794fdcf491d99
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L1-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7016
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7004
filingDate 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_adefc9c44e4009a9a6b4d9f66884e4bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f474a72981e3495cbd9b3dbcc45c05a3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f494089f00423d11cdb7a0266982d4c
publicationDate 2008-08-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008189638-A
titleOfInvention Blood sugar level rise inhibitor
abstract PROBLEM TO BE SOLVED: To provide a blood sugar level increase inhibitor capable of effectively suppressing an increase in blood sugar level after a meal using an uncompetitive inhibitor of sugar and a sugar-degrading enzyme. The present invention relates to a blood glucose level increase inhibitor that suppresses an increase in blood glucose level after a meal by being orally ingested in a period of 10 minutes to 6 hours before a meal. A blood sugar level increase inhibitor comprising 15 to 75 g of sugar as an active ingredient. Preferably, the content of the non-competitive inhibitor of sugar-degrading enzyme is 4 to 20% by weight of sugar, and the non-competitive inhibitor of sugar-degrading enzyme is L-arabinose, D-tagatose, D-xylose and these The blood sugar level elevation inhibitor is selected from the group consisting of a mixture and is in the form of a food or beverage. [Selection figure] None
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2017192021-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019517786-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11406680-B2
priorityDate 2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0665080-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2005289847-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP43471
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCF8DVG5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA5EZZ8
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ09122
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP27217
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ56660
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07819
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID439312
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13522
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO33833
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID4111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226517673
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ04937
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13394
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCA1STJ9
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID87088
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID5656984
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID92092
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP40714
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID87088
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ05936
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP37075
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0DJA7
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396106
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9KLT6

Total number of triples: 48.